Skip to content

Establishment of TCM treatment cohort for chronic obstructive pulmonary disease in Henan Province

Establishment of TCM treatment cohort for chronic obstructive pulmonary disease in Henan Province

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048060
Enrollment
Unknown
Registered
2021-06-29
Start date
2020-01-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Exposed group:treatment of Chinese medicine
The exposed group:Conventional treatment of western medicine

Sponsors

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for stable COPD; (2) Aged 40 to 80 years old; (3) It is consistent with the syndrome of deficiency of lung qi, deficiency of lung qi, deficiency of lung and kidney qi and deficiency of lung and kidney qi and Yin, or with the syndrome of blood stasis; (4) Signing the informed consent; (5) The patient is stable in work, can provide detailed contact information, and has no intention of short-term migration to cooperate with the visitors.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women and patients with a recent pregnancy plan; (2) patients with delirium, dementia and various mental diseases; (3) Tumor patients who underwent resection, radiotherapy and chemotherapy within 5 years; (4) patients with bronchial asthma, asthma-COPD overlap syndrome, bronchiectasis, active tuberculosis, and pulmonary embolism; (5) Patients with severe cardiovascular and cerebrovascular diseases (acute myocardial infarction, cardiac function grade 3 or above, stroke, etc.); (6) Complicated with serious liver and kidney disease (serious liver disease refers to cirrhosis, portal hypertension and hemorrhage of varicose veins, serious kidney disease includes dialysis and kidney transplantation).

Design outcomes

Primary

MeasureTime frame
Number of acute exacerbations of COPD per capita per year;

Secondary

MeasureTime frame
Case fatality rate and all-cause mortality rate;Queue mobility;Acute exacerbation of severity;Duration of acute exacerbation per capita per year;Lung function;clinical signs and symptoms;Dyspnea grade;Sports endurance;Quality of life;Patient Satisfaction with Efficacy;

Countries

China

Contacts

Public ContactSuyun Li

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

lisuyun2000@126.com+86 13938415502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026